Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
PhotoCide Protection
company
About
PhotoCide Protection develops self-disinfecting materials such fabrics, plastics, and coatings based on a disruptive technology.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $225K
- Industries
- Chemical,Manufacturing
- Founded date
- Jan 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
PhotoCide Protection develops self-disinfecting materials such fabrics, plastics, and coatings based on a disruptive technology that combines engineered cellulose (NFC) with photosensitizers (PS, compounds that react with room light and oxygen from the air) to emit an environmentally-friendly biocidal agent called ‘singlet’ oxygen that simultaneously destroys a wide range of harmful pathogens on surfaces.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$225K
PhotoCide Protection has raised a total of
$225K
in funding over 2 rounds. Their latest funding was raised on
May 29, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 29, 2020 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
PhotoCide Protection is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
